Edward P Rybicki
Overview
Explore the profile of Edward P Rybicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
2465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rybicki E, Williamson A, Venter M
Lancet Microbe
. 2025 Mar;
:101093.
PMID: 40058373
No abstract available.
2.
3.
Margolin E, Schafer G, Allen J, Gers S, Woodward J, Sutherland A, et al.
Front Plant Sci
. 2023 Mar;
14:1146234.
PMID: 36959936
Molecular farming of vaccines has been heralded as a cheap, safe and scalable production platform. In reality, however, differences in the plant biosynthetic machinery, compared to mammalian cells, can complicate...
4.
Adams A, Hendrikse M, Rybicki E, Hitzeroth I
Virology
. 2023 Feb;
580:88-97.
PMID: 36801669
Human papillomaviruses (HPVs) are known to be the cause of anogenital and oropharyngeal cancers as well as genital and common warts. HPV pseudovirions (PsVs) are synthetic viral particles that are...
5.
Buyse M, van Zyl A, Wimberger K, Boyes R, Carstens J, Rybicki E, et al.
J Wildl Dis
. 2022 Sep;
58(4):882-886.
PMID: 36136451
Psittacine beak and feather disease (PBFD) is one of the most important viral diseases affecting parrot species worldwide. Outbreaks of PBFD have been reported in wild endemic and endangered South...
6.
Ximba P, Chapman R, Meyers A, Margolin E, van Diepen M, Sander A, et al.
Nanotechnology
. 2022 Jul;
33(48).
PMID: 35882111
Two-component self-assembling virus-like particles (VLPs) are promising scaffolds for achieving high-density display of HIV-1 envelope (gp140) trimers, which can improve the induction of neutralising antibodies (NAbs). In this study gp140...
7.
Margolin E, Allen J, Verbeek M, Chapman R, Meyers A, van Diepen M, et al.
Biotechnol Bioeng
. 2022 Jul;
119(10):2919-2937.
PMID: 35781691
Heterologous glycoprotein production relies on host glycosylation-dependent folding. When the biosynthetic machinery differs from the usual expression host, there is scope to remodel the assembly pathway to enhance glycoprotein production....
8.
de Moor W, Regnard G, Rybicki E, Williamson A
J Gen Virol
. 2022 May;
103(5).
PMID: 35594121
nucleic expression technologies using DNA or mRNA offer several advantages for recombinant gene expression. Their inherent ability to generate natively expressed recombinant proteins and antigens allows these technologies to mimic...
9.
Lentzos F, Rybicki E, Engelhard M, Paterson P, Sandholtz W, Reeves R
Science
. 2022 Mar;
375(6587):1363.
PMID: 35324313
No abstract available.
10.
Whittle L, Chapman R, van Diepen M, Rybicki E, Williamson A
Vaccines (Basel)
. 2022 Feb;
10(2).
PMID: 35214669
The current method to protect cattle against East Coast Fever (ECF) involves the use of live sporozoites. Although this provides immunity, using live parasites has many disadvantages, such as contributing...